Short interest in AbCellera Biologics Inc (NASDAQ:ABCL) decreased during the last reporting period, falling from 17.35M to 16.64M. This put 7.32% of the company's publicly available shares short.

Short interest for AbCellera Biologics gives investors a sense of the degree to which investors are betting on the decline of AbCellera Biologics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.88M shares traded per day, it would take 8.85 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.